Roche to further reduce Genentech stake

According to DNA, Roche has filed with the SEC to sell 19 million DNA shares. The sale will reduce the pharma company's ownership in DNA to 59 percent from 65.6 percent. DNA was down $22.25 (11 percent) to $187.50 on the day. Based on that close, Roche would raise $3.6 billion through the sale. ...